Recent News

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Nov 20, 2025 7:46:07 AM

Patent adds to Envoy Medical's expanding intellectual property portfolio, reinforcing the Company's ...

Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial

Nov 18, 2025 9:09:54 AM

The trials expansion highlights the Company's clinical momentum and growing confidence in the device...

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 10, 2025 8:06:29 AM

Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 mi...

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Nov 4, 2025 8:53:07 AM

Rapid patient enrollment underscores strong market interest and reinforces commercialization opportu...

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving its Breakthrough Fully Implanted Cochlear Implant

Oct 29, 2025 7:00:02 AM

The Company looks to build on its recent momentum – receiving FDA approval to expand its Pivotal Cli...

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 27, 2025 8:31:15 AM

White Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2025) - Envoy Medical, Inc. (NASDAQ: COCH)...

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025 8:47:56 AM

The Company expects to complete full enrollment by early 2026 and is moving its timelines up three t...

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 25, 2025 9:42:06 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 25, 2025) - Envoy Medical® Inc. (NASDAQ: COC...

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 24, 2025 9:03:19 AM

The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Accl...

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 22, 2025 8:45:24 AM

White Bear Lake, Minnesota--(Newsfile Corp. - September 22, 2025) - Envoy Medical® Inc. (NASDAQ: COC...

*The materials and resources presented are intended to be an educational resource for general purposes only. They are not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician. Each person’s situation is unique and risks, outcomes, experience and results may vary. CAUTION: The fully implanted Acclaim Cochlear Implant is an investigational device. Limited by federal (or United States) law to investigational use.

**See Important Information here.

News Room